The rising frequency of methicillin resistant Staphylococcus aureus (MRSA) has led to an increased use of antibiotics such as macrolide, lincosamide, streptogramin B (MLS B ) for the treatment of S. aureus infections. Resistance to MLS B in S. aureus is commonly encoded by erm genes, which can be constitutive MLS B (cMLS B ) or inducible MLS B (iMLS B ). The purpose of this study was to determine the frequency of cMLS B , iMLS B , and MS phenotypes using D-test and polymerase chain reaction (PCR) methods. Materials and Methods: A total of 215 isolates of S. aureus were collected from January 2010 to May 2012 from Al-Zahra Hospital in Isfahan. PCR was performed for detection of mecA gene on all isolates using specific primers. The frequency of MLS B -resistant isolates was determined using D-test, and then a multiplex PCR was performed for detection of ermA, ermB, and ermC genes. Results: Among 215 S. aureus isolates examined, 82 (40.9%) were MRSA, and iMLS B , cMLS B , and MS resistance phenotypes had a frequency of 9 (4.18%), 58 (26.9%), and 11 (5.1%), respectively. Among nine isolates with iMLS B resistance phenotype, four isolates contained ermC gene, two isolates ermB gene, and one isolate ermA gene. Two isolates did not have any erm gene. Conclusion: In the current study, cMLS B was the most frequent phenotype and ermC was the most common gene in iMLS B resistant phenotypes. 
INTRODUCTION
Staphylococcus aureus is one of the most frequent pathogens that cause both community and hospital-acquired infections worldwide. Development of drug resistance in S. aureus has led to the use of older antibiotics such as macrolide, lincosamide, and streptogramin B (MLS B ) antibiotic. [1, 2] However,
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extensive use of these antibiotics in serious staphylococcal infections has caused the emergence of S. aureus resistant to MLS B antibiotics. [3] There are three different mechanisms of resistance to MLS B antibiotics including: (1) Active efflux mechanism encoded by msr gene, (2) drug inactivation encoded by lun gene and (3) ribosomal binding site modification (by methylation or mutation in the 23s rRNA gene) encoded by erm genes (ermA, ermB, ermC, and ermF) among which, ermA and ermC are predominant genes responsible for resistance to MLS B antibiotics in staphylococci, which can be constitutive or inducible. [4] [5] [6] [7] [8] In vitro, S. aureus isolates with constitutive MLS B (cMLS B ) resistance are resistant to erythromycin and clindamycin but isolates with inducible MLS B (iMLS B ) resistance are resistant to erythromycin and susceptible to clindamycin. In this condition, treatment of patients with clindamycin can lead to the emergence of resistant mutants to cMLS B from iMLS B -resistant strains and treatment failure. [3, 6] On the other hand, assigning all erythromycin-resistant S. aureus as clindamycin resistant strains may cause to avoid the use of clindamycin in the treatment of S. aureus infections. For this reason, careful screening of iMLS B -resistant strains is very important. While constitutive resistance is detectable by routine antimicrobial susceptibility tests, inducible resistance to clindamycin is not detectable by standard methods. [4, 5] For detection of iMLS-resistant strains, Clinical and Laboratory Standards Institute (CLSI) developed a phenotypic method called the double disk diffusion test (D-test). [9] [10] [11] [12] The aim of this study was to determine the frequency of inducible resistance to clindamycin using D-test and polymerase chain reaction (PCR) with specific primers to confirm the presence of the erm genes in these isolates.
MATERIALS AND METHODS

Bacterial strains and phenotypic testing
A total of 215 clinical isolates of S. aureus were collected from Al-Zahra Hospital in Isfahan from January 2010 to May 2012. Bacterial isolates were obtained from various clinical specimens including: Wound, blood, urine, sputum, etc., Early identification was performed based on Gram-staining and positive biochemical reactions such as catalase, coagulase, and DNase tests. D-test method was performed according to the CLSI guidelines using clindamycin (2 µg) and erythromycin (15 µg) disks (Himedia-India). For this purpose, suspensions of bacteria were prepared in the sterile saline (2 ml) equivalent to standard 0. Molecular detection of mecA gene DNA was extracted from 215 S. aureus isolates using Fermentas K0512 DNA kit (Fermentas-USA) in accordance with the manufacturer's protocol. PCR reaction was carried out for the amplification of the 310 bp fragment of mecA gene using primers as exhibited in Table 1 . PCR amplification reaction mixture (25 µL) contained 4 µL of DNA template, 2.5 µL of PCR buffer (×10), 0.75 µL Mgcl 2 (50 mM), 0.5 µL of dNTPs (10 mM), 1 µL of each primers (2 µL totally), 0.25 µL of Ex-Taq DNA polymerase (5u/µL) and 15 µL distill water. PCR conditions were as follows: Initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 30 s and extension at 72°C for 30 s, and final extension at 72°C for 7 min.
Multiplex polymerase chain reaction for erm gene
Multiplex PCR was performed for detection of erm gene in D-test positive isolates using specific primers for the ermA, B and C genes as exhibited in Table 1 . Each PCR was performed in a final volume of 25 µL consisting of 5 µL of DNA template, 2.5 µL of PCR buffer (×10), 1 µL Mgcl 2 (50 mM), 0.5 µL of dNTPs (10 mM), 0.75 µL of each primers (2 µL totally), 0.25 µL of Ex-Taq DNA polymerase (5 u/µL), 11.25 µL distill water. DNA was amplified on a thermocycler (Ependorf-Germany), and PCR conditions were as follows: Initial denaturation at 94°C for 10 min, 35 cycles of denaturation at 94°C for 30 s, annealing at 53°C for 30 s, and extension at 72°C for 60 s, followed by a final extension at 72°C for 10 min. 
RESULTS
In this study, 215 isolates of S. aureus were collected from various clinical specimens, wound 53 (24.6%), blood 49 (22.79%), urinary tract infection 30 (13.9%), sputum 35 (16.27%), abscess 21 (9.76) and others 27 (12.55%), from Al-Zahra Hospital in Isfahan. The patient's average age was 47 years (ranged 1-88 years). The mecA gene screening in all isolates showed that 82 (40.9%) of the 215 tested isolates were methicillin resistant S. aureus (MRSA) and mecA positive [ Figure 2 ]. Furthermore, double disk diffusion test results revealed that 134 (62.3%) of the isolates were susceptible to both clindamycin and erythromycin and 81 (37.7%) were shown to have four different resistance phenotypes in which 58 (26.9%) isolates were resistant phenotype to cMLS B (resistant to both erythromycin and clindamycin), 9 (4.18%) isolates were resistant phenotype to iMLS B (resistant to erythromycin and susceptible to clindamycin), 11 (5.1%) isolates were MS resistance phenotype (susceptible to clindamycin and resistant to erythromycin) and finally, 3 (1.39%) isolates were susceptible to erythromycin and resistant to clindamycin [ Figure 3 ]. Among nine isolates with iMLS B resistance phenotype, 5 (55.5%) were MRSA. Nine staphylococcal isolates with iMLS B resistance phenotype were tested for the presence of the erm genes, the ermA gene in 1 (11.1%) isolate, the ermB gene in 2 (22.2%) isolates, the ermC gene in 4 (44.4%) isolates was detected and two isolates did not have any erm genes [ Figure 3 ].
DISCUSSION
D-test results in our study demonstrated that 134 (62.3%) isolates were sensitive to both erythromycin and clindamycin; the frequency of cMLSB, iMLS B , and MS phenotypes were found to be 58 (26.9%), 9 (4.18%), and 11 (5.1%), respectively. In addition, the frequency of ermC, ermB, and ermA genes among isolates with iMLS B phenotype was determined to be 44.4%, 22.2%, and 11.1% respectively. Clindamycin due to its advantages including low-cost, low side effects, and good tissue penetration is used for the treatment of S. aureus infections. Although it is a good alternative in allergic patients instead of β-lactam antibiotics; [1, 9, 14, 15] however, excessive use of this antibiotic has an important role in bacterial resistance to clindamycin. Since the treatment of infected patients with resistant strains to iMLS B can lead to the expansion of constitutive resistance (cMLS B ) and therapy failure with clindamycin, detection of resistant strains to iMLS B is important from other resistance phenotypes. Since the frequency of cMLS B , iMLS B , and MS phenotypes varies in different geographical areas, even among different hospitals, awareness of regional frequency of MLS B resistant isolates is important for laboratories to decide for performing the D-test routinely or reporting all erythromycin-resistant S. aureus as clindamycin resistant. [7, 10, 12, 16] ermB CCGTTTACGA AATTGGAACA GGTAAAGGGC GAATCGAGAC TTGAGTGTGC 359 [13] ermC GCTAATATTG TTTAAATCGT CAATTCC GGATCAGGAA AAGGACATTT TAC 572 [13] mecA AAAATCGATGGTAAAGGTTGGC AGTTCTGCAGTACCGGATTTG 310 [14] Advanced Biomedical Research | 2016
In the current study, 82 (40.9%) isolates were found to be MRSA that is, comparable with a study conducted by Seifi et al. [5] Also, 6.09% of MRSA isolates had resistant phenotype to iMLS B , which is lower than those reported by Shoja et al. [17] In the current study, 134 (62.3%) isolates were sensitive to both erythromycin and clindamycin and the frequency of cMLS B , iMLS B and MS phenotypes were found to be 58 (26.9%), 9 (4.18%), and 11 (5.1%) respectively. Similar results were reported by Aslanimehr et al. [18] In the present study, the frequency of cMLS B phenotype was higher than iMLS B phenotype. Similar results were obtained by Memarian et al. [19] and Mahesh et al. [20] In contrast, Reddy and Suresh found the frequency of iMLS B phenotype to be higher than cMLS B phenotype. [3] In our study, the frequency of MS resistance phenotype was shown to be higher than iMLS B phenotype, which was concordant to some previous studies. [3, 5, 7] Incidentally, we detected 3 (1.39%) isolates resistant to clindamycin and susceptible to erythromycin, similar results were also obtained by Coutinho et al. [10] In addition, Seifi et al. reported 6 (2.84%) S. aureus isolates with such a phenotype. [5] This phenotype can be created by lincosamide nucleotide transferase enzyme that only inactivates lincosamide (clindamycin). Therefore, we investigated erm gene distribution among isolates with iMLS B phenotype. Our results revealed the frequency of ermC, ermB, and ermA genes among isolates with iMLS B phenotype to be 44.4%, 22.2%, and 11.1%, respectively. Two isolates with iMLS B phenotype were negative in genotypic test.
It must be noted that the frequency of erm genes is variable in different studies. According to our findings, the ermC gene was the most prevalent gene, similar study was performed by Aktas et al. in Turkey, [7] while in a study conducted by Saderi et al. ermA gene was prevalent (60%) among erythromycin-resistant S. aureus. [2] An interesting point to notice in our study was the high frequency of ermB gene, Similar results were shown in some studies. [21, 22] 
CONCLUSION
This report has investigated the frequency of inducible resistance to clindamycin using D-test and PCR methods. This was the first study to investigate the frequency of MLS B phenotypes in Isfahan which demonstrated cMLS B resistance to be the most prevalent resistance phenotype, ermC gene as the most common gene among iMLS-resistant S. aureus and iMLS B phenotype having a low frequency. Therefore, we do not recommend the routine performance of D-test but since the frequency of different resistance phenotype may change through time with the emergence of strains with different antibiotic susceptibility patterns, it is recommended that local periodic survey be performed.
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